S&P 500 Futures
(0.20%) 5 141.75 points
Dow Jones Futures
(0.19%) 38 513 points
Nasdaq Futures
(0.27%) 17 893 points
Oil
(-0.92%) $83.08
Gas
(1.56%) $1.953
Gold
(-0.16%) $2 343.40
Silver
(0.87%) $27.49
Platinum
(0.26%) $924.50
USD/EUR
(-0.18%) $0.933
USD/NOK
(-0.16%) $11.01
USD/GBP
(-0.24%) $0.798
USD/RUB
(1.08%) $92.87

实时更新: WuXi AppTec Co., Ltd. [2359.HK]

交易所: HKSE 部门: Healthcare 工业: Diagnostics & Research
最后更新时间29 Apr 2024 @ 15:15

3.27% HKD 36.35

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 15:15):

WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally...

Stats
今日成交量 9.57M
平均成交量 10.39M
市值 129.11B
EPS HKD0.940 ( 2023-10-31 )
Last Dividend HKD0.989 ( 2023-06-05 )
Next Dividend HKD0 ( N/A )
P/E 10.39
ATR14 HKD0.0660 (0.18%)

音量 相关性

長: -0.18 (neutral)
短: -0.05 (neutral)
Signal:(39.376) Neutral

WuXi AppTec Co., Ltd. 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

WuXi AppTec Co., Ltd. 相关性 - 货币/商品

The country flag -0.12
( neutral )
The country flag 0.08
( neutral )
The country flag 0.00
( neutral )
The country flag -0.32
( neutral )
The country flag -0.19
( neutral )
The country flag -0.25
( neutral )

WuXi AppTec Co., Ltd. 财务报表

Annual 2023
营收: HKD40.34B
毛利润: HKD16.61B (41.18 %)
EPS: HKD3.27
FY 2023
营收: HKD40.34B
毛利润: HKD16.61B (41.18 %)
EPS: HKD3.27
FY 2022
营收: HKD39.35B
毛利润: HKD14.68B (37.30 %)
EPS: HKD3.15
FY 2021
营收: HKD22.90B
毛利润: HKD8.31B (36.28 %)
EPS: HKD1.820

Financial Reports:

No articles found.

WuXi AppTec Co., Ltd. Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0.989
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)

WuXi AppTec Co., Ltd. Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.38 - Increase likely (47.54%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend HKD0.281 2019-06-17
Last Dividend HKD0.989 2023-06-05
Next Dividend HKD0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 5 --
Total Paid Out HKD2.45 --
Avg. Dividend % Per Year 0.00% --
Score 3.55 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 7.38
Div. Directional Score 10.00 --
Next Divdend (Est)
(2025-03-31)
HKD1.307 Estimate 3.09 %
Dividend Stability
0.25 Very Poor
Dividend Score
3.55
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
2314.HK Ex Dividend Junior 2023-08-11 Semi-Annually 0 0.00%
1283.HK Ex Dividend Junior 2023-09-22 Semi-Annually 0 0.00%
0341.HK Ex Dividend Junior 2023-09-12 Annually 0 0.00%
6083.HK Ex Dividend Knight 2023-06-12 Semi-Annually 0 0.00%
1843.HK Ex Dividend Knight 2023-09-05 Annually 0 0.00%
0868.HK Ex Dividend Knight 2023-08-11 Semi-Annually 0 0.00%
0016.HK Ex Dividend Knight 2023-11-06 Semi-Annually 0 0.00%
2633.HK Ex Dividend Knight 2023-08-15 Semi-Annually 0 0.00%
1412.HK Ex Dividend Knight 2023-06-12 Semi-Annually 0 0.00%
0497.HK Ex Dividend Junior 2023-08-25 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2381.5005.247.86[0 - 0.5]
returnOnAssetsTTM0.1301.2005.656.78[0 - 0.3]
returnOnEquityTTM0.1871.5009.0410.00[0.1 - 1]
payoutRatioTTM0.287-1.0007.13-7.13[0 - 1]
currentRatioTTM2.060.8004.693.75[1 - 3]
quickRatioTTM1.6100.8005.244.19[0.8 - 2.5]
cashRatioTTM0.9331.5005.938.89[0.2 - 2]
debtRatioTTM0.0780-1.5008.70-10.00[0 - 0.6]
interestCoverageTTM61.331.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM4.202.008.6010.00[0 - 30]
freeCashFlowPerShareTTM2.352.008.8310.00[0 - 20]
debtEquityRatioTTM0.104-1.5009.58-10.00[0 - 2.5]
grossProfitMarginTTM0.4121.0006.476.47[0.2 - 0.8]
operatingProfitMarginTTM0.2941.0006.116.11[0.1 - 0.6]
cashFlowToDebtRatioTTM2.181.00010.0010.00[0.2 - 2]
assetTurnoverTTM0.5480.8009.687.75[0.5 - 2]
Total Score12.79

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM10.581.0009.030[1 - 100]
returnOnEquityTTM0.1872.509.3810.00[0.1 - 1.5]
freeCashFlowPerShareTTM2.352.009.2210.00[0 - 30]
dividendYielPercentageTTM2.901.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM4.202.008.6010.00[0 - 30]
payoutRatioTTM0.2871.5007.13-7.13[0 - 1]
pegRatioTTM0.5261.5009.830[0.5 - 2]
operatingCashFlowSalesRatioTTM0.3111.0004.740[0.1 - 0.5]
Total Score7.38

WuXi AppTec Co., Ltd.

WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。